Publications by authors named "Martin Havrda"

Claim this Profile
U
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality.
Eli Zolotov, Anat Sigal, Martin Havrda, Maria Raskova, David Girsa

Kidney Blood Press Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhood.
Dana Thomasová, Michaela Zelinová, Malgorzata Libik, Jan Geryk, Pavel Votýpka, Martin Havrda

Front Med (Lausanne)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report: Acute kidney injury with progression to chronicity in an eldery woman.
Olga Snížková, Karolína Krátká, Martin Havrda, Ivan Rychlík, Mayara Elisa Knížek Bonatto

Cesk Patol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Glomerulonephritides associated with infections].
Martin Havrda

Vnitr Lek· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?
Eli Zolotov, Anat Sigal, Martin Havrda, Karolína Jeřábková, Karolína Krátká

Kidney Blood Press Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[More safe anticoagulant treatment - use of idarucizumab (Praxbind®): case reports from RE-VERSE AD study and clinical practice].
David Tuček, Tomáš Veleta, Martin Havrda

Vnitr Lek· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioptically Proven "Anticoagulation-Related Nephropathy" Induced by Dual Antiplatelet Therapy.
Karolína Krátká, Martin Havrda, Eva Honsová, Ivan Rychlík

Case Rep Nephrol Dial· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical case: idelalisib-induced immunoglobulin flare.
Jan Novak, Martin Havrda, Lubica Gaherova, Jan Spicka, Tomas Kozak

Immunopharmacol Immunotoxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term effect of evidence-based medicine heart failure therapy on glomerular filtration rate in elderly patients with chronic cardiorenal syndrome.
Filip Málek, Martin Havrda, Zuzana Fruhaufová, Jana Vránová

J Am Geriatr Soc· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis